Who's Blogging
- Rene Buest
- Malcolm Hawker
- Rick Franzosa
- Bart Willemsen
- Bill Ray
- Merv Adrian
- Deborah Wilson
- Olive Huang
- Andrew White
- Jack Mackinnon
- Rajesh Kandaswamy
- Dave Egloff
- Scot Kim
- Ed Gabrys
- Andrew Lerner
- Colin Reid
- Raj Bala
- Don Scheibenreif
- Jennifer Polk
- Stephen White
- Marty Resnick
- Mark P. McDonald
- Rajesh Narayan CPCU
- John Collins
- Melissa Minkow
- Jitendra Subramanyam
- Craig Roth
- Andrew Frank
- Chris Ross
- John A. Wheeler
- Augusto Barros
- Julian Poulter
- Anthony J. Bradley
- Samantha Searle
- Pedro Pacheco
- Clare Dietz
- Nicole Greene
- Consumer & Culture Insight Team
- Darin Stewart
- Emily Moquin
- Kate Muhl
- Avivah Litan
- Vivek Swaminathan
- Deacon D.K. Wan
- Charles Golvin
- Hank Barnes
- Tony Iams
- Daniel Sanchez Reina
- Srijita Chakraborty
2 x Life Science Hype Cycles
by Michael Shanler | July 29, 2017
While the spring rains drenched the northeastern U.S. and parts of Europe, Jeff, Steve, and I were hard at work authoring, arranging, writing, reviewing, re-reviewing, re-re-reviewing our content. After countless...
A CIO’s 24 Hours of Le Mans
by Michael Shanler | June 28, 2017
CIOs are competing in an endurance race. Winning requires carefully orchestrated activities that rely on technology, team work, precision driving, and a bit of luck. As in racing, the victorious...
Hey Ya! Cool Vendors in R&D is out…
by Michael Shanler | May 22, 2017
“…Now what's cooler than bein' cool? (Ice cold!)…” - André "André 3000" Benjamin from OutKast André 3000" is the 9th most influential rapper of all time according to Rateyourmusic.com. He’s in...
Hype Cycle for Life Science R&D
by Michael Shanler | July 25, 2016
This year, we unveiled a brand new hype cycle, one that is 100% Life Science R&D-focused. “… the moon does not present the same face every day. It waxes, or grows larger, until...
Mutate the DNA of Pharma Externalization
by Michael Shanler | May 12, 2016
Here’s a prediction. Life Science CxOs that continue to oversimplify “externalized innovation” strategies are in for a career-ending surprise in a few years. For details, check this out: Industry...
Cool Vendors in Life Science
by Michael Shanler | April 18, 2016
Allegra, Benadryl, Sudafed, Flonase, Claritin, Zyrtec, Tavist…. Why mention these drugs at this point in time? Well…Spring is finally here. Each season many of us spend some quality time with...
Dealing with Electronic Trial Masterphobia...
by Michael Shanler | April 5, 2016
There's an eTMF monster hiding under the bed… Well, not really...but I did recently have a conversation with a pharma R&D CIO (btw- he pre-approved me to blog about this) who...
Hey Pharma, Did you listen to Elon?
by Michael Shanler | April 3, 2016
The Tesla Model 3 was unveiled a few days ago. There are already over 250,000 people plopping down $1,000 deposits to reserve a product they haven’t physically seen or touched...
“Accelerating R&D” Key Initiatives for Life Science Manufacturers 2016
by Michael Shanler | January 27, 2016
Before each calendar year begins, we put a lot of effort into outlining areas of research and how these areas align with strategic key initiatives (KIs). The life science-related KIs...
IDMP Compliance Storm is Brewing for Pharma in the EU
by Michael Shanler | January 25, 2016
As we dig out in the US from the Winter Storm "Jonas" (aka #Snowmaggedon, #Snowpocalpyse #Blizzgazzhi, #Blizzard2016) and deal with snarled traffic, delayed flights and rescheduled meetings...it reminds me that...
